Update from the International Society on Hypertension in Blacks

Reviews in Cardiovascular Medicine

Volumn 3, Issue 4, 2002, Pages 192-195

  McCullough, Peter A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

African Americans; Aldosterone receptor blockers; Angiotensin receptor blockers; Atherosclerosis; Cardiovascular disease; Chronic kidney disease; End stage renal disease; Hypertension; Microalbuminuria

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR; AMLODIPINE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; METOPROLOL; PLACEBO; RAMIPRIL; RENIN;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONFERENCE PAPER; DIABETIC NEPHROPATHY; ETHNIC GROUP; HEART ARREST; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MEDICAL SOCIETY; PATIENT CARE; PATIENT COMPLIANCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CLINICAL TRIALS; HUMANS; HYPERTENSION; KIDNEY DISEASES;

EID: 0036763294     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Levin A, Stevens L, McCullough PA. Cardiovascular disease and the kidney. Tracking a killer in chronic kidney disease. Postgrad Med. 2002;111:53-60.
2. National Kidney Foundation Kidney Disease Outcomes Quality Initiative Guideline. Am J Kidney Dis. 2002;39(suppl 2):S32-S36.
3. Hayashi T, Suzuki A, Shoji T, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis. 2000;35:250-256.
4. Seliger SL, Weiss NS, Gillen DL, et al. HBG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kedney Int. 2002;61:297.
5. Jackson JH. Determinants of uncontrolled blood pressure in an African American hypertensive population [abstract 017]. In: Program and abstracts of the International Society on Hypertension in Blacks' 17th International Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Minority Populations; June 8-12,2002; Miami, FL.
6. White WB, Carr AA, Lewin A, et al. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinic blood pressure in 400 patients with systemic hypertension: results from a pivotal multinational trial [abstract 020]. In: Program and abstracts of the International Society on Hypertension in Blacks' 17th International Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Minority Populations; June 8-12,2002; Miami, FL.
7. Saunders E, Flack JM, Ferdinand K, et al. Eplerenone, the selective aldosterone blocker, is superior to losartan for the treatment of hypertension in blacks [abstract 021]. In: Program and abstracts of the International Society on Hypertension in Blacks' 17th International Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Minority Poputions; June 8-12,2002; Miami, FL.